Our data show that FSTL1 levels are significantly reduced in OSA patients compared to non-OSA controls, supporting the hypothesis that FSTL1 might be linked to the pathophysiological mechanisms of OSA, which might involve inflammation and oxidative stress. This evidence concerns the gene FSTL1 and obstructive sleep apnea syndrome.